High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

This study is currently recruiting participants.

Study NCT00637767 Information provided by National Cancer Institute (NCI)

First Received: March 14, 2008 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)